Cellulase variants
Abstract
The present invention relates to a method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of: a. constructing a multiple alignment of at least two amino acid sequences known to have three-dimensional structures similar to endoglucanase V (EGV) from Humicola insolens known from Protein Data Bank entry 4ENG; b. constructing a homology-built three-dimensional structure of the cellulolytic enzyme based on the structure of the EGV; c. identifying amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å; d. identifying surface-exposed amino acid residues of the enzyme; e. identifying all charged or potentially charged amino acid residue positions of the enzyme; f. choosing one or more positions wherein the amino acid residue is to be substituted, deleted or where an insertion is to be provided; and g. carrying out the substitution, deletion or insertion by using conventional protein engineering techniques. Also described are cellulase variants obtained by this method.
Claims
exact text as granted — not AI-modified1 - 78 . (canceled)
79 . A method of producing an enzyme variant, comprising introduction a mutation in the amino acid sequence of a parent endoglucanase at one or more positions selected from the group consisting of:
2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 21a, 22, 24, 25, 26, 28, 29, 32, 33, 34, 35, 37, 40, 42, 42a, 43, 44, 45, 47, 48, 49, 49a, 49b, 50, 53, 54, 55, 58, 59, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 79, 80, 82, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 95, 95d, 95h, 95j, 96, 97, 98, 99, 100, 101, 102, 103, 104, 106, 110, 111, 112, 113, 114, 115, 116, 117, 119, 121, 123, 127, 128, 129, 130, 131, 132, 132a, 133, 134, 136, 137, 138, 139, 140, 140a, 141, 143a, 145, 146, 147, 148, 149, 150b, 150e, 150j, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160c, 160e, 160k, 161, 162, 163, 164, 165, 166, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 183, 184, 185, 186, 188, 191, 192, 193, 195, 196, 197, 200, and 201, wherein each mutation is independently a substitution, insertion or deletion, the enzyme variant has endoglucanase activity and each position is numbered according to the amino acid sequence of the cellulase of SEQ ID NO: 1.
80 . The method of claim 79 , wherein the parent endoglucanase comprises the amino acid sequence of SEQ ID NO: 1.
81 . The method of claim 79 , wherein the mutation is one or more of the following:
K13L or L13K; P14A or A14P; S15H or H15S; K20E, K20G, K20A, E20K, G20K, A20K, E20G, E20A, G20E, A20E, G20A, or A20G; K21N or N21K; A22G, A22P, G22A, P22A, G22P, or P22G; V24*, V24L, *24V, L24V, *24L, or L24*; V28A, V28L, A28V, L28V, A28L, or L28A; N32D, N32S, N32K, D32N, S32N, K32N, D32S, D32K, S32D, K32D, S32K, or K32S; N34D or D34N; I38L, I38F, I38Q, L38I, F38I, Q38I, L38F, L38Q, F38L, Q38L, F38Q, or Q38F; S45N or N45S; G46S or S46G; E48D, E48N, D48E, N48E, D48N, or N48D; G50N or N50G; A53S, A53G, A53K, S53A, G53A, K53A, S53G, S53K, G53S, K53S, G53K, or K53G; Y54F or F54Y; W62F or F62W; A63D or D63A; V64I, V64D, I64V, D64V, I64D, or D64I; N65S, N65D, N65E, S65N, D65N, E65N, S65D, S65E, D65S, E65S, D65E, or E65D; D66N, D66P, D66T, N66D, P66D, T66D, N66P, N66T, P66N, T66N, P66T, or T66P; F68V, F68L, F68T, F68P, V68F, L68F, T68F, P68F, V68L, V68T, V68P, L68V, T68V, P68V, L68T, L68P, T68L, P68L, T68P, or P68T; A69S, A69T, S69A, T69A, S69T, or T69S; L70Y or Y70L; G71A or A71G; F72W, F72Y, W72F, Y72F, W72Y, or Y72W; A73G or G73A; A74F or F74A; T75V, T75A, T75G, V75T, A75T, G75T, V75A, V75G, A75V, G75V, A75G, or G75A; G79T or T79G; W85T or T85W; A88Q, A88G, A88R, Q88A, G88A, R88A, Q88G, Q88R, G88Q, R88Q, G88R, or R88G; Y90For F90Y; L92A or A92L; T93Q, T93E, Q93T, E93T, Q93E, or E93Q; T95E or E95T; S96T or T96S; G97T, G97A, T97G, A97G, T97A, or A97T; P98A or A98P; V99L or L99V; M104L or L104M; V106F or F106V; S110N or N110S; T111I, T111V, I111T, V111T, I111V, or V111I; G113Y or Y113G; L115V or V115L; G116S, G116Q, S116G, Q116G, S116Q, or Q116S; N118T, N118G, N118Q, T118N, G118N, Q118N, T118G, T118Q, G118T, Q118T, G118Q, or Q118G; H119Q, H119N, Q119H, or N119H; V129L or L129V; I131L, I131A, L131I, A131I, L131A, or A131L; G134A or A134G; Q138E or E138Q; G140N or N140G; R146Q or Q146R; S152D or D152S; R153K, R153L, R153A, K153R, L153R, A153R, K153L, K153A, L153K, A153K, L153A, or A153L; L163V, L163W, V163L, W163L, V163W, or W163V; G166S or S166G; W169F or F169W; R170F or F170R; F171Y, F171A, Y171F, A171F, Y171A, or A171Y; D172E, D172S, E172D, S172D, E172S, or S172E; W173E or E173W; F174M, F174W, M174F, W174F, M174W, or W174M; A177N or N177A; D178P or P178D; N179V or V179N; P180L or L180P; L193I or I193L; R196I, R196K, I196R, K196R, I196K, or K196I; and/or T197S or S197T.
82 . The method of claim 79 , wherein the mutation is one or more of the following:
in position 4 holds R, H, K, Q, V, Y, or M; in position 5 holds S, T, or A; in position 13 holds K, or L; in position 14 holds P, or A; in position 15 holds H, or S; in position 16 holds C, or A; in position 19 holds A, D, S, P, T, or E; in position 20 holds A, E, G, or K; in position 21 holds K, or N; in position 21a holds V or *; in position 22 holds A, G, or P; in position 24 holds L, V, or *; in position 28 holds A, L, or V; in position 32 holds D, K, N, or S; in position 34 holds D or N; in position 38 holds F, I, L, or Q; in position 42 holds D, G, T, N, S, K, or *; in position 44 holds K, V, R, Q, G, or P; in position 45 holds N, or S; in position 46 holds G, or S; in position 47 holds C, or Q; in position 48 holds D, E, N, or S; in position 49 holds P, S, A, G, or *; in position 49a holds C, or *; in position 49b holds N, or *; in position 50 holds G, or N; in position 53 holds A, G, K, or S; in position 54 holds F, or Y; in position 62 holds F, or W; in position 63 holds A, or D; in position 64 holds D, I, or V; in position 65 holds D, E, N, or S; in position 68 holds D, N, P, or T; in position 69 holds A, S, or T; in position 70 holds L, or Y; in position 71 holds A, or G; in position 72 holds F, W, or Y; in position 73 holds A, or G; in position 74 holds A, or F; in position 75 holds A, G, T, or V; in position 79 holds G, or T; in position 82 holds E, or *; in position 88 holds A, G, Q, or R; in position 90 holds F, or Y; in position 92 holds A, or L; in position 93 holds E, Q, or T; in position 95 holds E, or T; in position 95j holds P, or *; in position 96 holds S, or T; in position 97 holds A, G, or T; in position 98 holds A, or P; in position 99 holds L, or V; in position 104 holds L, or M; in position 106 holds F, or V; in position 110 holds N, or S; in position 111 holds I, T, or V; in position 113 holds G, or Y; in position 115 holds L, or V; in position 116 holds G, Q, or S; in position 118 holds G, N, Q, or T; in position 119 holds H, N, or Q; in position 129 holds L, or V; in position 131 holds A, I, or L; in position 132 holds A, P, or T; in position 133 holds D, K, N, or Q; in position 134 holds A, or G; in position 138 holds E, or Q; in position 145 holds A, D, N, or Q; in position 146 holds Q, or R; in position 150b holds A, or *; in position 152 holds D, or S; in position 153 holds A, K, L, or R; in position 163 holds L, V, or W; in position 166 holds G, or S; in position 169 holds F, or W; in position 170 holds F, or R; in position 171 holds A, F, or Y; in position 172 holds D, E, or S; in position 173 holds E, or W; in position 174 holds F, M, or W; in position 177 holds A, or N; in position 178 holds D, or P; in position 179 holds N, or V; in position 180 holds L, or P; in position 193 holds I, or L; in position 196 holds I, K, or R; and/or in position 197 holds S, or T.
83 . The method of claim 79 , wherein the mutation is one or more of the following: C16M+C86G, D42W, D42Y, E48D/P49*, E48N/P49* and/or L70Y.
84 . The method of claim 79 , wherein the mutation is one or more of the following:
K13L or L13K; P14A or A14P; S15H or H15S; K20E, K20G, K20A, E20K, G20K, A20K, E20G, E20A, G20E, A20E, G20A, or A20G; K21N or N21K; A22G, A22P, G22A, P22A, G22P, or P22G; V24*, V24L, *24V, L24V, *24L, or L24*; N32D, N32S, N32K, D32N, S32N, K32N, D32S, D32K, S32D, K32D, S32K, or K32S; N34D or D34N; G50N or N50G; A53S, A53G, A53K, S53A, G53A, K53A, S53G, S53K, G53S, K53S, G53K, or K53G; Y54F or F54Y; V64I, V64D, I64V, D64V, 164D, or D64I; F68V, F68L, F68T, F68P, V68F, L68F, T68F, P68F, V68L, V68T, V68P, L68V, T68V, P68V, L68T, L68P, T68L, P68L, T68P, or P68T; A69S, A69T, S69A, T69A, S69T, or T69S; L70Y or Y70L; G71A or A71G; G79T or T79G; W85T or T85W; A88Q, A88G, A88R, Q88A, G88A, R88A, Q88G, Q88R, G88Q, R88Q, G88R, or R88G; L92A or A92L; T93Q, T93E, Q93T, E93T, Q93E, or E93Q; V106F or F106V; Q138E or E138Q; G140N or N140G; S152D or D152S; R153K, R153L, R153A, K153R, L153R, A153R, K153L, K153A, L153K, A153K, L153A, or A153L; G166S or S166G; W169F or F169W; R170F or F170R; F171Y, F171A, Y171F, A171F, Y171A, or A171Y; D172E, D172S, E172D, S172D, E172S, or S172E; W173E or E173W; F174M, F174W, M174F, W174F, M174W, or W174M; L193I or I193L; and/or T197S or S197T.
85 . The method of claim 79 , wherein the mutation is one or more of the following:
the amino acid residue at position 22 is A, G, or P; the amino acid residue at position 24 is L, V, or *; the amino acid residue at position 32 is D, K, N, or S; the amino acid residue at position 34 is D or N; the amino acid residue at position 42 is D, G, T, N, S, K, or *; the amino acid residue at position 49 is P, S, A, G, or *; the amino acid residue at position 49a is C or *; the amino acid residue at position 49b is N or *; the amino acid residue at position 50 is G or N; the amino acid residue at position 53 is A, G, K, or S; the amino acid residue at position 54 is F or Y; the amino acid residue at position 64 is D, I, or V; the amino acid residue at position 68 is D, N, P, or T; the amino acid residue at position 69 is A, S, or T; the amino acid residue at position 70 is L or Y; the amino acid residue at position 71 is A or G; the amino acid residue at position 79 is G or T; the amino acid residue at position 88 is A, G, Q, or R; the amino acid residue at position 92 is A or L; the amino acid residue at position 93 is E, Q, or T; the amino acid residue at position 95j is P or *; the amino acid residue at position 106 is F or V; the amino acid residue at position 138 is E or Q; the amino acid residue at position 150b is A or *; the amino acid residue at position 152 is D or S; the amino acid residue at position 153 is A, K, L, or R; the amino acid residue at position 166 is G or S; the amino acid residue at position 169 is F or W; the amino acid residue at position 170 is F or R; the amino acid residue at position 171 is A, F, or Y; the amino acid residue at position 172 is D, E, or S; the amino acid residue at position 173 is E or W; the amino acid residue at position 174 is F, M, or W; the amino acid residue at position 193 is I or L; and/or the amino acid residue at position 197 is S or T.Join the waitlist — get patent alerts
Track US2011250674A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.